ACCESS to Better Care: Things to Know About CMS's ACCESS Innovation Model
Aug 28, 2026 - 10:29
Radio and PodcastLive Radio & PodcastsBusiness
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast
In this episode, Rebecca Schaefer, Michael Hinckle, and Elisabeth Lewis summarize FDA regulatory developments from 2023 and what to expect in 2024 as it relates to clinical research. They discuss the significance of the...
Related Episodes
Continue listening to more episodes from K&L Gates Health Care Triage.
What the FDA's Botox Warning Letter Means for DSCSA Compliance
Aug 5, 2026 - 12:00
No Surprises Act Check-In: The Latest Changes to the IDR Process
Jun 23, 2026 - 08:23
HIPAA Modernization: HHS's Proposed Privacy and Security Rule Updates
May 26, 2026 - 10:44
Privileged Matters: A Closer Look at Attorney-Client Privilege
May 19, 2026 - 12:58
LEAD the Way: An 8-Minute Primer on Accountable Care's Next Chapter
Apr 16, 2026 - 08:06
340B Drug Pricing Program: Rebate Model Considerations
Mar 25, 2026 - 09:28